血管活性药物对脓毒性休克微循环的影响:范围综述
本范围综述检索MEDLINE、Embase和Cochrane Central Register of Controlled Trials,纳入1946年至2025年5月7日期间接受血管活性药物治疗并同步进行微循环测量的成人脓毒性休克研究,共33项。研究设计异质性大,24小时内招募患者的研究倾向于报告更显著的微循环变化。微循环变化与心指数仅39%一致,提示全身血流动力学与微血管灌注脱节。去甲肾上腺素、血管加压素、特利加压素和左西孟旦显示情境依赖的外周/舌下微循环改善;多巴酚丁胺可能增强灌注,但直接监测胃微循环受限,需进一步研究支持多巴酚丁胺及其他血管活性药物对临床结局的影响。
要点
- 纳入33项成人脓毒性休克研究,24小时内招募患者的研究倾向于报告更显著的微循环变化。
- 微循环变化与心指数仅39%一致,提示全身血流动力学与微血管灌注存在脱节。
- 去甲肾上腺素、血管加压素、特利加压素和左西孟旦在特定情境下显示外周/舌下微循环改善。
- 多巴酚丁胺可能增强灌注,但直接监测胃微循环受限,需进一步研究支持其对临床结局的影响。
- 尽管灌注导向治疗兴趣增长,血管活性药物如何影响微循环仍存在显著挑战。
适用人群与场景
- 成人脓毒性休克患者,接受血管活性药物治疗并同步进行微循环测量。
研究设计与关键结果
- 范围综述纳入33项研究,评估多种血管活性药物和微循环测量技术。
- 研究设计异质性大,24小时内招募患者的研究倾向于报告更显著的微循环变化。
- 微循环变化与心指数仅39%一致。
- 去甲肾上腺素、血管加压素、特利加压素和左西孟旦显示情境依赖的外周/舌下微循环改善。
- 多巴酚丁胺可能增强灌注,但直接监测胃微循环受限,需进一步研究支持其对临床结局的影响。
证据类型、等级与局限
- 证据类型:范围综述。
- 局限:研究设计异质性大;直接监测胃微循环受限;需进一步研究支持多巴酚丁胺和其他血管活性药物对临床结局的影响。
对床旁实践的改变
- 微循环变化与心指数仅39%一致,提示不能仅凭全身血流动力学指标推断微血管灌注状态。
- 去甲肾上腺素、血管加压素、特利加压素和左西孟旦在特定情境下可能改善外周/舌下微循环,但证据为情境依赖。
- 多巴酚丁胺可能增强灌注,但直接监测胃微循环受限,作者认为需进一步研究支持其对临床结局的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To summarize knowledge and identify gaps in evidence regarding the effects of vasoactive medications on microvascular perfusion in septic shock.
DATA SOURCES: We conducted a comprehensive search of MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials.
STUDY SELECTION: Studies included adult patients with septic shock who received vasoactive therapy with corresponding microcirculatory measurements between 1946 and May 7, 2025.
DATA EXTRACTION: Data extraction was performed in Covidence by two independent reviewers. Data items included study design, patient population, vasoactive medication, macrohemodynamics, and microcirculation measurements and techniques.
DATA SYNTHESIS: Thirty-three studies were included evaluating several vasoactive medications and microvascular measurement techniques. Despite heterogeneous study design, studies that recruited patients within 24 hours tended to report more significant microcirculatory changes. Microcirculatory changes and cardiac index only aligned in 39% of cases, highlighting a disconnect between global hemodynamics and microvascular perfusion. Several vasoactives, including norepinephrine, vasopressin, terlipressin, and levosimendan demonstrated context-dependent improvements in peripheral/sublingual microcirculation. Despite limitations in directly monitoring gastric microcirculation, dobutamine may enhance perfusion; however, further studies are needed to support dobutamine and other vasoactive agents' impacts on clinical outcomes.
CONCLUSIONS: Despite growing interest in perfusion-guided care, significant challenges remain in understanding how vasoactive agents affect the microcirculation. Clarifying these effects through standardized research and point-of-care perfusion monitoring remains a challenge in advancing outcome-driven resuscitation strategies.
参考来源
- Sathianathan S, Sachar S, Berro J, et al. Vasoactive Medications and the Microcirculation in Septic Shock: A Scoping Review. Crit Care Med. 2026. PMID: 41528192. doi:10.1097/CCM.0000000000007016
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。